Table 2. Lung cancer CT screening: randomised studies.
| Study | Country | Study design | Year started | Subjects enrolled | Age range (years) | Years screen |
|---|---|---|---|---|---|---|
| LSS (Gohagan et al, 2005) | USA | CT vs CXR | 2000 | 3318 | 55–74 | 2 |
| DANTE (Infante et al, 2008) | Italy | CT vs obs | 2001 | 2472 | 60–74 | 4 |
| NLST (Clark et al, 2008) | USA | CT vs CXR | 2002 | 53 000 | 55–74 | 3 |
| NELSON (van den Bergh et al, 2008) | NL–B | CT vs obs | 2003 | 15 822 | 50–74 | 5 |
| ITALUNG (Lopes Pegna et al, 2009) | Italy | CT vs obs | 2004 | 3206 | 55–69 | 5 |
| DLCST (Pedersen et al, 2009) | DK | CT vs obs | 2004 | 4104 | 50–70 | 5 |
| MILD (Pastorino et al, 2006) | Italy | CT vs obs | 2005 | 4479 | 49–75 | 10 |
| LUSI (Becker et al, 2008) | Germany | CT vs obs | 2007 | 4000 | 50–69 | 5 |
Abbreviation: CT=computed tomography; CXR=chest X-ray; DLCST=Danish Lung Cancer Screening Trial; LSS=Lung Screening Study; MILD=Multicentric Italian Lung Detection; NL–BM=the Netherlands and Belgium; NLST=National Lung Screening Trial; obs=observational studies.